- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging drugs for the treatment of kidney disease-induced anemia
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 21, Issue 3, Pages 315-330
Publisher
Informa UK Limited
Online
2016-08-18
DOI
10.1080/14728214.2016.1220537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients
- (2016) Roberto Minutolo et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial
- (2016) Richard A. Brigandi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- New Treatment Approaches for the Anemia of CKD
- (2016) Mario Bonomini et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
- (2016) Robert Provenzano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
- (2016) R. Provenzano et al. Clinical Journal of the American Society of Nephrology
- Iron Balance and the Role of Hepcidin in Chronic Kidney Disease
- (2016) Tomas Ganz et al. SEMINARS IN NEPHROLOGY
- A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
- (2015) Geoffrey A. Block et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Thiol-derivatized minihepcidins retain biological activity
- (2015) Eileen Fung et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Small cyclic agonists of iron regulatory hormone hepcidin
- (2015) Kristine Chua et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer® therapeutics
- (2015) Axel Vater et al. DRUG DISCOVERY TODAY
- Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
- (2015) K. Umanath et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
- (2015) A. Besarab et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients
- (2015) Ajay Gupta et al. KIDNEY INTERNATIONAL
- Anemia: progress in molecular mechanisms and therapies
- (2015) Vijay G Sankaran et al. NATURE MEDICINE
- Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients
- (2015) J. Floege et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
- (2015) Anatole Besarab et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model
- (2015) Marit M. Suttorp et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers
- (2014) Kenneth M. Attie et al. AMERICAN JOURNAL OF HEMATOLOGY
- Erythroferrone contributes to recovery from anemia of inflammation
- (2014) L. Kautz et al. BLOOD
- Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine -thalassemia
- (2014) R. N. V. S. Suragani et al. BLOOD
- Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans
- (2014) L. T. van Eijk et al. BLOOD
- Long-Term Safety and Efficacy of a Novel Iron-Containing Phosphate Binder, JTT-751, in Patients Receiving Hemodialysis
- (2014) Keitaro Yokoyama et al. JOURNAL OF RENAL NUTRITION
- Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis
- (2014) J. B. Lewis et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients
- (2014) Jürgen Floege et al. KIDNEY INTERNATIONAL
- An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
- (2014) Michael Dussiot et al. NATURE MEDICINE
- Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
- (2014) Rajasekhar N V S Suragani et al. NATURE MEDICINE
- Targeting a new regulator of erythropoiesis to alleviate anemia
- (2014) Robert F Paulson NATURE MEDICINE
- Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects
- (2014) Ingo Flamme et al. PLoS One
- Comparison of 2-Week Versus 4-Week Dosing Intervals of Epoetin Beta Pegol on Erythropoiesis and Iron Metabolism in Hemodialysis Patients
- (2014) Yuki Morikami et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Phosphorus binding with ferric citrate is associated with fewer hospitalizations and reduced hospitalization costs
- (2014) Roger Rodby et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience
- (2014) François Bocquet et al. Applied Health Economics and Health Policy
- A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates
- (2013) K. S. Cooke et al. BLOOD
- Greater potency of darbepoetin-αthan erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients
- (2013) Shigeichi Shoji et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblasts
- (2013) J. Malik et al. HAEMATOLOGICA
- Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair Responses
- (2013) Michael H. Rabinowitz JOURNAL OF MEDICINAL CHEMISTRY
- Iron toxicity: relevance for dialysis patients
- (2013) S. Fishbane et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A Low-Molecular-Weight Compound K7174 Represses Hepcidin: Possible Therapeutic Strategy against Anemia of Chronic Disease
- (2013) Tohru Fujiwara et al. PLoS One
- A long-acting erythropoietin fused with noncytolytic human Fc for the treatment of anemia
- (2012) Se Hwan Yang et al. ARCHIVES OF PHARMACAL RESEARCH
- Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
- (2012) Gregg L. Semenza TRENDS IN MOLECULAR MEDICINE
- Notice
- (2012) Kidney International Supplements
- Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
- (2011) Chia Chi Sun et al. AMERICAN JOURNAL OF HEMATOLOGY
- HIF prolyl hydroxylase inhibitors for anemia
- (2011) Eugene Muchnik et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Intestinal Hypoxia-inducible Factor-2α (HIF-2α) Is Critical for Efficient Erythropoiesis
- (2011) Erik R. Anderson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
- (2011) Kearkiat Praditpornsilpa et al. KIDNEY INTERNATIONAL
- Do two intravenous iron sucrose preparations have the same efficacy?
- (2011) J. Rottembourg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Oxygen Sensing, Homeostasis, and Disease
- (2011) Gregg L. Semenza NEW ENGLAND JOURNAL OF MEDICINE
- Natural Form of Noncytolytic Flexible Human Fc as a Long-Acting Carrier of Agonistic Ligand, Erythropoietin
- (2011) Se Jin Im et al. PLoS One
- PUK13 A COST MINIMIZATION ANALYSIS OF EPOETIN ZETA FOR THE TREATMENT OF ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE
- (2011) IV Pearson et al. VALUE IN HEALTH
- Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia
- (2010) B. J. Sasu et al. BLOOD
- A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys
- (2010) Sutada Lotinun et al. BONE
- 2009: A Requiem for rHuEPOs--But Should We Nail Down the Coffin in 2010?
- (2010) D. Goldsmith Clinical Journal of the American Society of Nephrology
- Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
- (2010) W. M. Bernhardt et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- 'Biosimilar' drugs poised to penetrate market
- (2010) Heidi Ledford NATURE
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current and Upcoming Erythropoiesis-Stimulating Agents, Iron Products, and Other Novel Anemia Medications
- (2009) Iain C. Macdougall et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools
- (2009) P. Sathyanarayana et al. BLOOD
- Intestinal Hypoxia-Inducible Transcription Factors Are Essential for Iron Absorption following Iron Deficiency
- (2009) Yatrik M. Shah et al. Cell Metabolism
- Pharmacokinetics and Pharmacodynamics of the Erythropoietin Mimetibody™ Construct CNTO 528 in Healthy Subjects
- (2009) Juan José Pérez-Ruixo et al. CLINICAL PHARMACOKINETICS
- Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy
- (2009) G. Weiss et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
- (2009) Damien R. Ashby et al. KIDNEY INTERNATIONAL
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I, Single and Fractionated, Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of an Erythropoietin Mimetic Antibody Fusion Protein (CNTO 528) in Healthy Male Subjects
- (2008) Esther Bouman-Thio et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now